The report covers Diagnostic Imaging Equipment Manufacturers in Europe and the market is Segmented on the basis of Modality, Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, and Other Applications), End-User and Geography.

The European Diagnostic Imaging Equipment Industry is valued at XX million in 2025 and is projected to reach XX million by 2033, exhibiting a CAGR of 5.60%. The market growth is attributed to the rising prevalence of chronic diseases, increasing healthcare expenditure, and technological advancements in imaging equipment. MRI (Low and Mid Field MRI Systems) is the largest segment, accounting for XX% of the market in 2025. Key industry players include Siemens Healthineers, GE Healthcare, Philips, and Canon Medical Systems. Europe remains a significant market for diagnostic imaging equipment, with Germany, the United Kingdom, France, Italy, and Spain being the major contributors. The rapid adoption of AI and Machine Learning in medical imaging and the increasing demand for personalized and precision medicine drive market growth. However, factors such as high equipment costs, data privacy concerns, and the availability of alternative diagnostic methods may restrain the market's expansion. Key drivers for this market are: , Increase in Geriatric Population and Rising Prevalence of Chronic Diseases; Technological Advancement in Imaging Modalities; Rising Adoption of Medical Imaging Devices. Potential restraints include: , High Cost of Advanced Diagnostic Imaging Devices; Dearth of Radiologists. Notable trends are: Application in Oncology is Expected to Witness the Fastest Growth over the Forecast Period.

Concerning the seven selected segments, the segment Siemens Healthineers has the largest value share by brand with 30.01 percent. Contrastingly, Fujifilm is ranked last, with 2.53 percent. Their difference, compared to Siemens Healthineers, lies at 27.48 percentage points. Find more statistics on other topics: a comparison of the value share by brand in Asia and a comparison of the value share by brand in the world. The Statista Market Insights cover a broad range of additional markets.

Explore Diagnostic Imaging Market Regional Demand with our comprehensive analysis. Get insights on North America, Asia Pacific, Europe, and other key regions. Access country-level market data and understand market dynamics and growth potential across different regions.

The Report Covers the Diagnostic Imaging Market Size and Share and It is Segmented by Modality (MRI, Computed Tomography, Ultrasound, X-Ray, Nuclear Imaging, Fluoroscopy, and Mammography), Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, and Other Applications), End Users (Hospitals, Diagnostic Centers and Other End Users) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Market Size is Provided in Terms of Value (in USD) During the Projected Period for the Above Segments

The global medical imaging market, valued at $42.38 billion in 2025, is projected to experience robust growth, driven by several key factors. Technological advancements, such as the development of AI-powered diagnostic tools and improved image resolution techniques across modalities like MRI and CT scans, are significantly enhancing diagnostic accuracy and efficiency. This, coupled with a rising geriatric population globally predisposed to chronic diseases requiring frequent imaging, fuels market expansion. Furthermore, increasing healthcare expenditure in developing economies and growing adoption of minimally invasive procedures reliant on precise imaging guidance are contributing to market growth. The segmental analysis reveals that X-ray imaging currently holds the largest market share due to its widespread availability and relatively lower cost compared to advanced imaging techniques. However, the MRI and CT scanner segments are anticipated to witness the fastest growth rates, fueled by technological advancements and increasing demand for high-resolution imaging in complex diagnostic scenarios. Hospitals remain the primary end-users, but the diagnostic imaging center segment is expected to grow rapidly as these specialized facilities gain popularity. Competitive intensity is moderate, with key players focusing on strategic collaborations, product innovation, and geographical expansion to maintain their market positions. While regulatory hurdles and high equipment costs can pose some challenges, the overall market outlook remains exceptionally positive. The market's geographical distribution reflects developed nations' higher healthcare spending and technological adoption rates. North America and Europe currently hold substantial market shares, although the Asia-Pacific region is demonstrating rapid growth potential, driven by increasing healthcare infrastructure investment and rising disposable incomes. This emerging market presents significant opportunities for market expansion, particularly in countries like China and India, where the demand for advanced medical imaging solutions is steadily escalating. The continued rise of telehealth and remote diagnostics is also likely to play a role, potentially increasing access to imaging services in underserved areas. The forecast period of 2025-2033 promises sustained market growth driven by the factors mentioned above, with a projection of substantial market expansion by the end of the forecast period.

Snapshot img

Refurbished Medical Imaging Equipment Market Size 2024-2028

The refurbished medical imaging equipment market size is forecast to increase by USD 6.74 billion at a CAGR of 8.09% between 2023 and 2028.

The market is experiencing significant growth, driven by the increasing demand for cost-effective and efficient medical imaging solutions. This trend is particularly prominent in the US market, where healthcare providers are seeking to reduce expenses without compromising patient care. Another key factor fueling market expansion is the growing adoption of eco-friendly practices in the healthcare industry. Refurbished medical imaging equipment offers an attractive alternative to new devices, as it reduces the carbon footprint associated with manufacturing and disposal. The preference for advanced digital X-ray systems is on the rise due to their superior image quality and versatility. However, the market also faces challenges, including the negative perception of end-users towards refurbished equipment. Some stakeholders harbor concerns about the reliability and quality of refurbished devices, which can hinder market penetration. To overcome this hurdle, market participants must focus on enhancing the transparency of their refurbishment processes and providing strong warranties and support services. By addressing these challenges and capitalizing on the market's growth drivers, companies can effectively capitalize on the opportunities presented by the market.

What will be the Size of the Market during the forecast period?

Request Free Sample

The market encompasses the sale and maintenance of pre-owned diagnostic tools, primarily in the healthcare sector. With the global burden of chronic diseases on the rise, the demand for cost-effective medical imaging solutions has increased. Refurbishment offers tax benefits for healthcare providers, enabling them to acquire advanced technology while adhering to capital budget constraints. Diagnostic players, IVD and laboratories, surgical and therapeutic facilities, and patient monitoring units increasingly turn to refurbished equipment for cardiology, ecofriendly practices, and chronic condition management.
Outsourcing contracts for maintenance and warranty services further boosts market growth. Regulatory standards ensure quality assurance, while emerging economies' increasing focus on sustainability fuels adoption rates. Despite budget constraints, the market's size and direction remain strong, with medical imaging continuing to play a crucial role in disease diagnosis and treatment.

How is this Refurbished Medical Imaging Equipment Industry segmented?

The refurbished medical imaging equipment industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Product

  X-ray imaging
  Ultrasound systems
  MRI
  CT scanner imaging
  SPECT/ PET scanners


End-user

  Hospitals
  Diagnostic centers


Geography

  North America

    US


  Europe

    Germany
    UK


  Asia
  Rest of World (ROW)

By Product Insights

The X-ray imaging segment is estimated to witness significant growth during the forecast period. X-ray imaging, a non-invasive diagnostic technique, accounts for over 50% of imaging procedures in healthcare settings. These systems are increasingly used in various clinical, scientific, and industrial applications. The demand for refurbished X-ray equipment, such as X-ray machines and C-arms, is growing due to budget constraints and the availability of tax benefits. Refurbished equipment undergoes rigorous quality assurance processes to meet regulatory standards, ensuring patient safety and diagnostic accuracy. Key chronic diseases like cardiovascular diseases and dental conditions significantly contribute to the demand for medical imaging, including X-ray systems.

Get a glance at the market report of share of various segments Request Free Sample

The X-ray imaging segment was valued at USD 2.79 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

Asia is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market size of various regions, Request Free Sample

The North American market for refurbished medical imaging equipment is primarily driven by the rise in chronic diseases such as cardiovascular diseases, musculoskeletal disorders, and cancer. Favorable regulatory policies and cost savings from using refurbished equipment are additional factors contributing to its growth. The US dominates this market due to the absence of restrictions on the sale, purchase, and

The global medical imaging market is experiencing robust growth, driven by technological advancements, an aging population with increasing prevalence of chronic diseases, and rising healthcare expenditure globally. The market is segmented by imaging modality (e.g., X-ray, CT, MRI, ultrasound, nuclear medicine) and application (e.g., diagnostics, therapeutic guidance, research). Technological innovations such as AI-powered image analysis, improved image resolution, and minimally invasive procedures are significantly impacting market growth. The integration of advanced imaging technologies with electronic health records (EHRs) and telehealth platforms is further fueling market expansion. While high equipment costs and stringent regulatory approvals present challenges, the long-term growth outlook remains positive, driven by increasing demand for advanced diagnostic tools and improved patient care. Major players like FUJIFILM, GE Healthcare, Philips, Siemens Healthineers, and Toshiba Medical Systems are actively engaged in research and development, strategic acquisitions, and partnerships to maintain their market positions and expand their product portfolios. Regional growth varies, with North America and Europe currently dominating the market due to high healthcare spending and advanced infrastructure. However, Asia-Pacific is projected to experience significant growth in the coming years, driven by rising healthcare awareness and increasing investments in healthcare infrastructure in emerging economies. The competitive landscape is characterized by both large multinational corporations and smaller specialized companies. Market consolidation through mergers and acquisitions is expected to continue, leading to greater innovation and improved efficiency. The increasing adoption of cloud-based solutions and big data analytics in medical imaging is transforming workflows and enhancing diagnostic capabilities. Furthermore, the focus on personalized medicine and precision diagnostics is driving demand for sophisticated imaging technologies capable of providing detailed anatomical and functional information. This trend, along with continuous improvements in image quality, resolution, and speed, will further propel the growth of the medical imaging market in the coming decade. Government initiatives aimed at improving healthcare infrastructure and access to quality care, especially in developing nations, will also contribute significantly to market expansion.

In 2019, the breast imaging market was valued at 229 million U.S. dollars in Germany, while in the UK it was valued at 190 million U.S dollars. Germany is forecast to retain the largest market value in the breast imaging industry.

Europe Nuclear Imaging Market size was valued at USD 2.67 Billion in 2024 and is projected to reach USD 4.48 Billion by 2032, growing at a CAGR of 6.7% from 2026 to 2032.

Europe Nuclear Imaging Market Dynamics

The key market dynamics that are shaping the Europe Nuclear Imaging Market include:

Key Market Drivers

Aging Population and Increased Chronic Disease Prevalence: Europe’s aging population and increased frequency of chronic diseases are driving up demand for nuclear imaging. According to Eurostat, approximately 30% of Europeans will be over 65 by 2050, increasing the prevalence of age-related disorders such as cardiovascular disease, which accounts for 45% of all fatalities in the region. This demographic transition needs sophisticated diagnostic methods, as nuclear imaging allows for early identification, accurate monitoring, and effective therapy of such illnesses, resulting in better patient outcomes and lower healthcare expenditures.

The market is segmented by equipment (Radiography (X-ray) Systems, Ultrasound Imaging Systems, Computed Tomography Imaging Systems, Magnetic Resonance Imaging Systems, Video Endoscopy Imaging Systems, and Other Equipment), Application (Cardiology, Oncology, Neurology, Orthopedics, Other Applications), Animal Type (Small Animals, Large Animals), and Geography (North America, Europe, Asia-Pacific, Rest of World). The report offers the value (in USD million) for the above segments.

According to Cognitive Market Research, the global Radiology Service market size will be USD 27154.6 million in 2024. It will expand at a compound annual growth rate (CAGR) of 7.00% from 2024 to 2031.

North America held the major market share for more than 40% of the global revenue with a market size of USD 10861.84 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 8146.38 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 6245.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.0% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 1357.73 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 543.09 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031.
The stationary held the highest Radiology Service market revenue share in 2024.

Market Dynamics of Radiology Service Market

Key Drivers for Radiology Service Market

Rising Prevalence of Chronic Diseases to Increase the Demand Globally

The main factor influencing the demand for radiology services is the rising occurrence of illnesses linked to changes in dietary habits and lifestyle choices. Furthermore, imaging methods are employed to view the human body's architecture in order to identify, monitor, or treat particular illnesses. To decide on the best course of treatment for chronic conditions like cancer, respiratory issues, cardiovascular problems, and others, imaging procedures are necessary. The market's need for radiology services has increased as a result of it. The growing necessity and preference for minimally invasive procedures as a result of less expensive options and shorter hospital stays is also anticipated to hasten the market's overall expansion. In addition, the developing healthcare industry and the rising adoption of sophisticated data analytics technologies are anticipated to drive market expansion.

Growing Need for Radiological Services to Propel Market Growth

The goal of the field of radiology is to employ imaging techniques to diagnose and treat a wide range of ailments. Furthermore, because radiology services are highly effective at accurately diagnosing disorders, their popularity has grown over the past few years as more imaging modalities have been available in the medical industry. It has played a part in radiology's increasing popularity. In today's environment, radiologists are vital to the medical field. These assessments are carried out by radiographers, who also provide patients with psychological and practical support during imaging procedures. Increasing the number of patients who use radiology services depends heavily on this factor.

Restraint Factor for the Radiology Service Market

High Cost of Equipment and Procedures to Limit the Sales

It costs radiology service providers a lot of money to acquire and maintain sophisticated imaging devices like CT and MRI scanners. These equipment's growing costs provide a number of difficulties. Financial resources are strained by the high upfront expenditures of new equipment, which makes it harder to make investments in other business sectors. Increased expenses may affect profit margins, making it more challenging to maintain competitive pricing and make investments in cutting-edge technology. Patients' access to advanced imaging services may occasionally be restricted by the high cost of equipment, especially in impoverished areas.

Impact of Covid-19 on the Radiology Service Market

For the market for radiological services, the pandemic presented previously unheard-of opportunities as well as problems. The number of elective and non-emergency imaging operations was greatly decreased as a result of the emphasis on COVID-19 patients. Radiology practices had financial difficulties as a result of rising operating expenses (staffing, PPE) and declining revenue. It affected the purchase of supplies such as contrast agents and imaging equipment. Due to postponed screenings and operations, there is a pent-up need for diagnostic imag...

The size and share of the market is categorized based on Type (Conventional CT scanners, Cone beam CT scanners) and Application (Hospital, Imaging Diagnostic Centre, Other) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

This statistic displays the compound annual growth rate of the medical imaging information systems market in the European Union 5 countries forecast from 2008 to 2022. The CAGR of the medical imaging informations systems market is expected to reach 7.2 percent between 2015 and 2022.

The Europe Optical Imaging Market is segmented by Technology (Photoacoustic Tomography, Optical Coherence Tomography, Hyperspectral Imaging, Near-Infrared Spectroscopy), Product (Imaging Systems, Illumination Systems, Optical Imaging Software, Optical Imaging Software), Application Areas (Ophthalmology, Oncology, Cardiology, Dermatology, Neurology), Application (Pathological Imaging, Intraoperative Imaging), End-User Industry (Hospitals & Clinics, Research & Diagnostic Laboratories, Pharmaceutical Industry, Biotechnology Companies), and Country.

The size and share of the market is categorized based on Type (CT, X-ray, Ultrasound, Endoscope) and Application (Hospitals, Clinics) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

The size of the Europe Optical Imaging market was valued at USD XX Million in 2023 and is projected to reach USD XXX Million by 2032, with an expected CAGR of 14.20% during the forecast period.A non-invasive method of visualizing the inner body structures, optical imaging uses light. It uses visible light and near infrared to create very detailed images of parts of organs, tissues, even cellular structure. Nothing reveals subtle recognition better than to see parts of the human body using digital optical imaging in real time, like these. The market for optical imaging is growing much in Europe due to a few factors. Aging, chronic diseases, and continuous hikes in healthcare spending encourage the need for advanced diagnostic tools. Moreover, up-to-date technologies in optical imaging methods, such as OCT and fluorescence microscopy, have aided the earlier, more accurate detection of diseases. The European market is dominated by major players, which are heavily investing in research and development for introducing new innovative products. These companies are developing cost-effective optical imaging devices, which can be portable and user-friendly enough to cater to the increasing demand. The rate of innovation in this field has been accelerated through collaborations between academic institutions, research organizations, and industry players. Conclusion: The European market for optical imaging tends to enter a period of significant expansion in the near future. The use of optical imaging technologies will significantly grow in the region because the support from the governments and healthy infrastructures for healthcare. Over time, technology is sure to be essential in helping to improve patient care and enhance research in the medical field within Europe. Key drivers for this market are: , Rising Demand for ophthalmology; Advancements in technology. Potential restraints include: , High Initial cost of the equipment. Notable trends are: Ophthalmology Segment is Expected to Hold a Major Market Share.

Clinical X-ray Imaging Market Outlook

The clinical X-ray imaging market size was valued at approximately USD 14.8 billion globally in 2023 and is projected to reach around USD 22.6 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period. This growth is primarily driven by advancements in imaging technology, an aging population, and the rising prevalence of chronic diseases necessitating diagnostic imaging.

One of the primary growth factors for the clinical X-ray imaging market is the rapid advancements in imaging technology. The transition from analog to digital systems has significantly improved image quality, reduced radiation exposure, and provided enhanced diagnostic capabilities. Innovations such as 3D imaging and the integration of Artificial Intelligence (AI) to aid in image interpretation are also revolutionizing the field. These technological advancements not only improve diagnostic accuracy but also increase the efficiency of radiologists, thereby propelling market growth.

Another significant growth factor is the increasing incidence of chronic diseases like cardiovascular diseases, cancer, and orthopedic conditions, which require frequent and detailed imaging for diagnosis and treatment planning. The aging global population is a major contributor to this trend, as older adults are more susceptible to these conditions. The rising demand for early and accurate diagnosis is driving the need for advanced X-ray imaging solutions, thus contributing to market expansion.

The growing awareness and emphasis on preventive healthcare are further encouraging the adoption of X-ray imaging. Governments and healthcare organizations are increasingly focusing on early detection and regular health check-ups to mitigate the impact of chronic diseases. This shift in healthcare strategy is boosting the demand for diagnostic imaging services, including X-ray imaging. Additionally, favorable government initiatives and funding for healthcare infrastructure development are providing a conducive environment for market growth.

The integration of the X-Ray Real-Time Image System into healthcare facilities is revolutionizing diagnostic procedures by providing instant imaging results. This system allows for real-time visualization of internal structures, which is particularly beneficial in emergency and surgical settings where time is of the essence. By enabling immediate image acquisition and interpretation, healthcare providers can make swift and informed decisions, improving patient outcomes. The real-time capabilities of this system also enhance workflow efficiency, reducing the need for repeat scans and minimizing patient exposure to radiation. As healthcare continues to evolve, the adoption of real-time imaging systems is expected to grow, further driving advancements in diagnostic accuracy and patient care.

Regionally, North America holds the largest share in the clinical X-ray imaging market, followed by Europe and the Asia Pacific. The high adoption rate of advanced imaging technologies, well-established healthcare infrastructure, and significant healthcare expenditure are key factors driving the market in North America. The Asia Pacific region is expected to witness the highest growth rate, driven by increasing healthcare investments, rising patient awareness, and a booming medical tourism industry.

Product Type Analysis

The clinical X-ray imaging market by product type includes Digital X-ray Systems, Analog X-ray Systems, Mobile X-ray Systems, and Others. Digital X-ray systems dominate the market owing to their superior image quality, lower radiation doses, and the ability to store and share images digitally. These systems facilitate quicker diagnosis and treatment planning, making them the preferred choice in modern healthcare settings. The market for digital X-ray systems is further bolstered by continuous technological advancements, such as the development of portable and wireless systems, which enhance usability and patient comfort.

Analog X-ray systems, while gradually being replaced by digital counterparts, still hold a significant market share, particularly in developing regions. These systems are cost-effective and relatively easier to maintain, making them a viable option for smaller healthcare facilities and regions with limited access to advanced technology. However, the market share for analog systems is expected to decline over the forecast pe

The global pet diagnostic imaging market, valued at $668 million in 2025, is projected to experience robust growth, driven by several key factors. Increasing pet ownership worldwide, coupled with rising pet humanization trends, fuels demand for advanced veterinary care, including diagnostic imaging. Owners are increasingly willing to invest in sophisticated diagnostic tools to ensure their pets receive the best possible treatment, leading to higher utilization of X-ray, ultrasound, MRI, and CT scans. Technological advancements in pet imaging systems, such as smaller, more portable devices and improved image quality, further contribute to market expansion. The market is segmented by application (dog, cat, others) and by type of imaging technology, with X-ray and ultrasound currently dominating due to their relatively lower cost and widespread availability. However, the adoption of MRI and CT scans is expected to increase gradually as veterinary practices upgrade their facilities and pet owners opt for more detailed diagnostic information. Geographic growth will be largely driven by North America and Europe, which already have established veterinary infrastructure and high pet ownership rates. However, developing economies in Asia-Pacific are poised for significant growth, fueled by rising disposable incomes and growing awareness of advanced veterinary care. Market restraints include the high cost of advanced imaging technologies like MRI and CT, potentially limiting accessibility in certain regions and for some pet owners. The forecast period of 2025-2033 will see continued expansion, propelled by the aforementioned drivers. The 9.7% CAGR suggests a substantial increase in market size by 2033. Growth will likely be uneven across segments, with the "others" category (both application and technology) potentially witnessing faster growth than established segments due to innovation and the emergence of new technologies. Strategic partnerships between veterinary clinics and diagnostic imaging providers, coupled with the increasing availability of financing options for veterinary services, are also expected to boost market growth. Competition among established players like GE, IDEXX, and others will likely intensify as they strive to innovate and capture market share, potentially leading to further cost reductions and technological advancements. This competitive landscape fosters innovation and affordability, ultimately benefiting both veterinarians and pet owners.

Snapshot img

Clinical Trial Imaging Market Size 2024-2028

The clinical trial imaging market size is forecast to increase by USD 551.3 million at a CAGR of 7.5% between 2023 and 2028.

The market is experiencing significant growth due to the increasing investment in drug development for chronic diseases. Imaging techniques, such as Computed Tomography (CT), play a crucial role in clinical trials by providing valuable data for drug efficacy and safety assessments. Patient comfort is a key trend in this market, as Breast imaging technologies are being developed to minimize patient discomfort and improve the overall trial experience. Data management services are also gaining importance to ensure accurate and efficient handling of imaging data. Strict regulations, however, pose a challenge to market growth, requiring strong data security and compliance measures. Overall, the market is expected to continue its expansion, driven by the need for advanced imaging technologies to support the development of new treatments.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The integration of medical imaging technologies in clinical trials has revolutionized the biotechnology and pharmaceutical industries. By providing valuable insights into various health conditions, these advanced imaging techniques contribute significantly to the development of new therapeutics and treatments. In the realm of clinical trials, imaging technologies play a pivotal role in assessing the efficacy and safety of new drugs and therapies. Biotechnology and pharmaceutical companies increasingly rely on these technologies to gather data on disease progression, treatment response, and potential side effects. Image analysis software, fueled by artificial intelligence (AI) and machine learning algorithms, is a crucial component of this process. 



These advanced technologies enable the automated detection, measurement, and analysis of various health conditions, including oncology, non-alcoholic steatohepatitis (NASH), neurology, endocrinology, and cardiology. Virtual imaging trials, which utilize AI and machine learning, have gained considerable attention in recent years. These trials allow for remote patient monitoring and data collection, streamlining the clinical trial process and reducing costs. Imaging modalities, such as computed tomography (CT), magnetic resonance imaging (MRI), echocardiography, nuclear medicine (positron emission tomography – PET), x-ray, ultrasound, and optical coherence tomography, are essential tools in the clinical trial landscape.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Modality

  Computed tomography
  Magnetic resonance imaging
  Ultrasound
  Positron emission tomography
  Others


End-user

  Contract research organization
  Pharmaceutical and biotechnology companies
  Research and academic institutes
  Medical device manufacturers


Geography

  North America

    US


  Europe

    Germany
    UK


  Asia

    China
    Japan


  Rest of World (ROW)

By Modality Insights

The computed tomography segment is estimated to witness significant growth during the forecast period.

The market is experiencing notable progressions, with a notable focus on the computed tomography (CT) segment. CT imaging is a vital imaging modality in clinical trials due to its ability to generate detailed cross-sectional images of the body, which are crucial for precise diagnosis and tracking of various medical conditions, including cancer. The rising prevalence of chronic diseases and the demand for early and precise diagnosis have boosted the importance of high-resolution imaging technologies. CT scans are indispensable in evaluating disease progression and treatment effectiveness in clinical trials.

Furthermore, technological innovations in CT imaging, such as photon counting computed tomography (PCCT), are expanding the capabilities of clinical trial imaging. Magnetic Resonance Imaging (MRI), Echocardiography, Nuclear Medicine, Positron Emission Tomography (PET), and X-ray are other significant imaging modalities in clinical trials. MRI offers superior soft tissue contrast and is widely used in neurology, oncology, and cardiology trials. Hence, such factors are fuelling the growth of this segment during the forecast period.

Get a glance at the market report of share of various segments Request Free Sample

The computed tomography segment was valued at USD 317.40 million in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 38% to the growth of the global market during the